RxDoctor Payments Data

Kyler Black, MD

Internal Medicine · Roosevelt, UTNPI 1518499268

Payments from drug & device makers

$893in general payments, 2019–2025

Across 51 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$245
  • Lilly USA, LLC$138
  • Axsome Therapeutics, Inc.$70
  • AstraZeneca$58
  • Biohaven Pharmaceutical Holding Company Ltd.$49
  • Xeris Pharmaceuticals, Inc.$46
  • plus $287 from 11 others

What the payments were for

  • Food & beverage$893100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$893 in reported general payments places this provider in the 70th percentile of 496 internal medicine providers in Utah.

See all internal medicine providers in Utah

Medicare billing

Part B allowed, 2024
$4,593
Medicare patients
46
Services billed
109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban40$38,815
OzempicSemaglutide22$20,517
TrulicityDulaglutide21$19,989
FarxigaDapagliflozin Propanediol19$16,017
Tresiba Flextouch U-100Insulin Degludec11$4,957
LantusInsulin Glargine,hum.Rec.Anlog14$895
Potassium Chloride23$676
Omeprazole53$516
Gabapentin40$468
Levothyroxine Sodium37$349
Carvedilol15$335
Duloxetine Hcl11$303
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$292
Tamsulosin Hcl18$286
Pantoprazole Sodium36$284

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$25$20,51722 claims
Lilly USA, LLCTrulicity$138$19,98921 claims
AstraZenecaFarxiga$58$16,01719 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 496 internal medicine providers in Utah.

Other internal medicine in Roosevelt

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →